In This SectionTexas Health Research & Education Institute
Disease or Condition
Heart / Stent
Evaluation of drug (Everolimus) coated stent (Heart / Stent)
The primary objective of this study is to evaluate clinical outcomes in patients who receive the FDA-approved XIENCE V Everolimus Eluting Coronary Stent System (EECSS) over a five year period post surgery.
Patients who understand English and receive only XIENCE V EECSS stent(s).
Patients who don’t understand English and patients who receive other types of stents.